Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Status:
Recruiting
Trial end date:
2028-07-28
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized, parallel controlled, open-label study. The
primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative
adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The
Secondary purposes are to evaluate the safety of long-term use of Huaier granules as
postoperative adjuvant treatment of high-risk early-stage triple-negative invasive ductal
carcinoma, and the changes of quality of life score after treatment with Huaier granule.
Phase:
Phase 4
Details
Lead Sponsor:
Fudan University
Collaborators:
Huazhong University of Science and Technology LinkDoc Technology (Beijing) Co. Ltd.